MedicubeX

Finland
Helsinki, Uusimaa, Finland, 00290

Company profile

MedicubeX company profile

The world’s most accurate way to predict cardiovascular disease and diabetes risks non-invasively and without any assistance, enabling timely intervention, better outcomes, and reduced healthcare costs. The MedicubeX eHealth Station is a hospital-grade, fully autonomous and non-invasive screening booth. In just 5 minutes, it provides a comprehensive health check-up and risk stratification for CVD and T2D , generating a structured healthcare report that integrates seamlessly into hospital's EHR. MedicubeX’s proprietary, patent-pending AI algorithm delivers the world’s most accurate risk analysis for CVD and T2D , predicting an individual’s likelihood of heart attack, stroke, heart failure, and peripheral artery disease - entirely non-invasively and without the need for blood tests or clinical staff. Unique features: - Superior accuracy: Outperforms traditional blood-based methods in CVD risk prediction. - Non-Invasive & Fast: No blood, no staff; full screening in just minutes. - Clinically validated: Trusted by leading hospitals and research partners. - Seamless integration: Compatible with any telehealth and EHR systems. - Fast setup: Plug-and-play installation, operational within hours. - All-inclusive Saas model: Covers hardware, software, and 24/7 support.

Business identity

Contact email
[email protected]
Phone number
+358443001617
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2020-03-01, Month

Headquarters

Postal code
00290
Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
15
Total equity funding
$6.5M
Last funding
Equity Crowdfunding / $3.9M / 2025-11-06
Last equity funding
Equity Crowdfunding / $3.9M
Investors
3
Lead investors
2
Founders
2
Articles
31

Founders and investors

Founders

Heikki RautajokiVili Kostamo

Lead investors

Business FinlandIntersystems

Investors

Business FinlandIntersystemsSpringvest